Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.
Cairncross G, Swinnen L, Bayer R, Rosenfeld S, Salzman D, Paleologos N, Kaminer L, Forsyth P, Stewart D, Peterson K, Hu W, Macdonald D, Ramsay D, Smith A; Oligodendroglioma Study Group.
Cairncross G, et al. Among authors: forsyth p.
Neuro Oncol. 2000 Apr;2(2):114-9. doi: 10.1093/neuonc/2.2.114.
Neuro Oncol. 2000.
PMID: 11303620
Free PMC article.